| Name: | 7-(3-Buten-1-yloxy)-3,4-dihydro-2(1H)-quinolinone |
| Catalogue No. | VE008725 |
| CAS No. | 1359829-23-4 |
| Molecular Formula | C13H15NO2 |
| Molecular Weight | 217.26 g/mol |
| Status | In-Stock |
| IUPAC Name | 7-(3-Buten-1-yloxy)-3,4-dihydro-2(1H)-quinolinone |
| Description | 7-(3-Buten-1-yloxy)-3,4-dihydro-2(1H)-quinolinone CAS No: 1359829-23-4 1 is an impurity of Aripiprazole which is prescribed alone or together with other medicines to treat mental conditions like bipolar I disorder (manic-depressive illness), major depressive disorder, and schizophrenia. It is also prescribed to children to treat irritability associated with autistic disorder and Tourette syndrome. It is an antipsychotic agent |
| References | “Aripiprazole (Oral Route) Side Effects - Mayo Clinic.” Mayoclinic.org, 2015, www.mayoclinic.org/drugs-supplements/aripiprazole-oral-route/side-effects/drg-20066890?p=1 |
![Aripiprazole(N-3-(hydroxyphenyl)-3[(2-oxo-1H-quinoline-7-yl)oxy]propanamide)](/public/site/files/site_images/thumb_aripiprazole-n-3-hydroxyphenyl-3-2-oxo-1h-quinoline-7-yl-oxy-propanamide64113.png)
![Di-[2-(2,3-dichlorophenyl)aminoethyl]amine](/public/site/files/site_images/thumb_di-2-2-3-dichlorophenyl-aminoethyl-amine73090.png)
